Literature DB >> 11891940

Functional status after primary surgical therapy for squamous cell carcinoma of the base of the tongue.

Paul Friedlander1, Salvatore Caruana, Bhuvanesh Singh, Ashok Shaha, Dennis Kraus, Louis Harrison, Janet McKiernan, Jill Solan, Tatyana Polyak, Jatin P Shah.   

Abstract

INTRODUCTION: Quality-of-life analysis is essential in determining the eventual outcome after treatment for head and neck cancer. This is particularly important when functional sequelae of treatment cause significant morbidity. The purpose of this study is to evaluate the functional status of a group of patients who had undergone primary surgical therapy for squamous cell carcinoma of the base of the tongue.
METHODS: At our institution from 1979 to 1993, we identified 93 patients who had undergone resection of the base of the tongue as primary treatment for squamous cell carcinoma. Patients who required laryngectomy were excluded from this group. Forty-eight survivors were identified, and the questionnaires included the Performance Status Scale for Head and Neck Cancer Patients (PSS) and the Karnofsky Performance Status Scale (KPS). The data were reported numerically, with 0 representing the worst score and 100 representing the best score.
RESULTS: Twenty-six patients completed the questionnaires. There were 19 men and 7 women. Their mean survival time was 8.6 years. Two patients had their primary tumors staged as T1, 17 patients had T2, and 7 patients had T3 disease. When evaluating the normalcy of diet, the mean score for the whole group was 73.1 (range, 20-100), the mean score for understandability of speech was 80.8 (range, 50-100), and the mean score for eating in public was 79.8 (range, 0-00). The mean KPS was 90 (range, 60-100). When comparing early (T1 and T2) with advanced (T3) disease, there were no significant differences in PSS and KPS. When comparing younger (<50 years) with older (>50 years) patients, there were no significant differences in PSS scores. Younger patients had a significantly higher KPS than older patients: mean, 97.5 vs 86.4 (p <.02).
CONCLUSIONS: The long-term functional status for these patients who had undergone resection of a significant portion of the base of their tongue was good. The outcome did not seem to be related to either the stage of the lesion or the age of the patient. More studies are needed to examine the functional outcome of this patient population. Copyright 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2002        PMID: 11891940     DOI: 10.1002/hed.10015

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  10 in total

1.  Quality of life in patients after reconstruction with the supraclavicular artery island flap (SCAIF) versus the radial free forearm flap (RFFF).

Authors:  Jennifer L Spiegel; Yiannis Pilavakis; Bernhard G Weiss; Martin Canis; Christian Welz
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-05-27       Impact factor: 2.503

Review 2.  [Surgical treatment options in oropharyngeal cancer].

Authors:  Herwig Swoboda
Journal:  Wien Med Wochenschr       Date:  2008

3.  Oropharyngeal carcinoma and its treatment in Finland between 1995-1999: a nationwide study.

Authors:  Antti A Mäkitie; Matti Pukkila; Jussi Laranne; Jaakko Pulkkinen; Jyrki Vuola; Leif Bäck; Petri Koivunen; Reidar Grénman
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-07-08       Impact factor: 2.503

4.  Sociodemographic risk indicators for depressive symptoms among persons with oral cancer or oral epithelial dysplasia.

Authors:  Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai
Journal:  J Oral Maxillofac Surg       Date:  2005-04       Impact factor: 1.895

5.  Treatment Outcomes and Quality of Life in Oropharyngeal Cancer after Surgery-based versus Radiation-based Treatment.

Authors:  Tae Wook Kim; Hye-Youn Youm; Hayoung Byun; Young-Ik Son; Chung-Hwan Baek
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-09-17       Impact factor: 3.372

6.  [Quality of life after treatment of head and neck tumors : longitudinal comparison after operation and adjuvant radio(chemo)therapy].

Authors:  B M Bücheler; A Ehnes; M Kavsadze; S Langenberg; T Wilhelm-Buchstab; M Zipfel; S Keiner; A O H Gerstner
Journal:  HNO       Date:  2012-12       Impact factor: 1.284

7.  Bioactive phytochemical proanthocyanidins inhibit growth of head and neck squamous cell carcinoma cells by targeting multiple signaling molecules.

Authors:  Ram Prasad; Santosh K Katiyar
Journal:  PLoS One       Date:  2012-09-26       Impact factor: 3.240

8.  Honokiol inhibits the growth of head and neck squamous cell carcinoma by targeting epidermal growth factor receptor.

Authors:  Tripti Singh; Nirzari A Gupta; Su Xu; Ram Prasad; Sadanandan E Velu; Santosh K Katiyar
Journal:  Oncotarget       Date:  2015-08-28

9.  Early stage oropharyngeal carcinomas: comparing quality of life for different treatment modalities.

Authors:  Don-Felix Ryzek; Konstantinos Mantsopoulos; Julian Künzel; Philipp Grundtner; Johannes Zenk; Heinrich Iro; Georgios Psychogios
Journal:  Biomed Res Int       Date:  2014-02-25       Impact factor: 3.411

10.  Developing core sets for patients with head and neck cancer based on the International Classification of Functioning, Disability and Health (ICF).

Authors:  U Tschiesner; A Cieza; S N Rogers; J Piccirillo; G Funk; G Stucki; A Berghaus
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-06-14       Impact factor: 3.236

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.